{"status":"OK","data":{"advertisement":{"id":212666,"title":"Niekliniczne badanie farmakodynamicze prowadzone w projekcie pn. \"Opracowanie innowacyjnego produktu leczniczego w postaci kropli do oczu, stosowanych do obni\u017cenia ci\u015bnienia \u015br\u00f3dga\u0142kowego, wolnych od konserwant\u00f3w, dostarczanych w opakowaniu wielodawkowym\"","partial_offer_allowed":false,"publication_date":"2023-06-13","submission_deadline":"2023-06-16 23:59:59","planned_sign_date":"2023-06-01","supplementary_orders":"Zamawiaj\u0105cy zastrzega sobie prawo do udzielenia Wykonawcy zam\u00f3wienia uzupe\u0142niaj\u0105cego (zgodnego z opisem przedmiotu zam\u00f3wienia podstawowego) w wysoko\u015bci nieprzekraczaj\u0105cej 50% warto\u015bci zam\u00f3wienia podstawowego okre\u015blonej w umowie zawartej z Wykonawc\u0105.\n\nThe Ordering Party reserves the right to place with Contractor an additional contract (conforming to the Terms of Reference) for up to 50% of the original contract amount as agreed with Contractor.","terms_of_contract_change":"- zmiany przepis\u00f3w prawa Unii Europejskiej lub prawa krajowego, w zakresie maj\u0105cym wp\u0142yw na realizacj\u0119 Umowy (w szczeg\u00f3lno\u015bci zmiany stawek podatku VAT);\n- poprawienia parametr\u00f3w technicznych przedmiotu zam\u00f3wienia, wynikaj\u0105cych z aktualizacji rozwi\u0105za\u0144 z uwagi na post\u0119p technologiczny, bez wp\u0142ywu na cen\u0119 rycza\u0142tow\u0105 brutto\n- przed\u0142u\u017cenia terminu realizacji Umowy na skutek konieczno\u015bci wykonania prac dodatkowych, kt\u00f3rych wykonanie jest niezb\u0119dne dla nale\u017cytego wykonania Umowy, a kt\u00f3rych wykonania Zamawiaj\u0105cy, dzia\u0142aj\u0105c z nale\u017cyt\u0105 staranno\u015bci\u0105, nie m\u00f3g\u0142 wcze\u015bniej przewidzie\u0107, z zastrze\u017ceniem punktu poni\u017cej;\n- przed\u0142u\u017cenia terminu realizacji Umowy na skutek dzia\u0142ania si\u0142y wy\u017cszej wraz ze wszystkimi konsekwencjami wyst\u0119puj\u0105cymi w zwi\u0105zku z przed\u0142u\u017ceniem tego terminu;\n- zmiany parametr\u00f3w przedmiotu Umowy, nie prowadz\u0105ce do zmiany charakteru Umowy - zmiany technologiczne, w szczeg\u00f3lno\u015bci: konieczno\u015b\u0107 realizacji Umowy przy zastosowaniu innych rozwi\u0105za\u0144 technicznych/technologicznych, materia\u0142owych ni\u017c wskazane w Zapytaniu ofertowym, w sytuacji, gdy zastosowanie przewidzianych rozwi\u0105za\u0144 grozi\u0142oby niewykonaniem lub wadliwym wykonaniem Umowy, z zastrze\u017ceniem punktu poni\u017cej;\n- zmiany dotycz\u0105 realizacji dodatkowych dostaw lub us\u0142ug Wykonawcy, nieobj\u0119tych Umow\u0105, o ile sta\u0142y si\u0119 niezb\u0119dne i zosta\u0142y spe\u0142nione \u0142\u0105cznie nast\u0119puj\u0105ce warunki:\n- zmiana Wykonawcy nie mo\u017ce zosta\u0107 dokonana z powod\u00f3w ekonomicznych lub technicznych, w szczeg\u00f3lno\u015bci dotycz\u0105cych zamienno\u015bci lub interoperacyjno\u015bci sprz\u0119tu, us\u0142ug lub instalacji, zam\u00f3wionych w ramach podstawowego przedmiotu Umowy,\n- zmiana Wykonawcy spowodowa\u0142aby istotn\u0105 niedogodno\u015b\u0107 lub znaczne zwi\u0119kszenie koszt\u00f3w dla Zamawiaj\u0105cego,\n- warto\u015b\u0107 ka\u017cdej kolejnej zmiany nie przekracza 50% warto\u015bci pierwotnego przedmiotu Umowy netto;\n- zmiana nie prowadzi do zmiany charakteru Umowy i zosta\u0142y spe\u0142nione \u0142\u0105cznie nast\u0119puj\u0105ce warunki:\n- konieczno\u015b\u0107 zmiany Umowy spowodowana jest okoliczno\u015bciami, kt\u00f3rych Zamawiaj\u0105cy, dzia\u0142aj\u0105c z nale\u017cyt\u0105 staranno\u015bci\u0105, nie m\u00f3g\u0142 przewidzie\u0107,\n- warto\u015b\u0107 zmiany nie przekracza 50% warto\u015bci pierwotnego przedmiotu Umowy netto;\n- Wykonawc\u0119 ma zast\u0105pi\u0107 nowy wykonawca:\n- w wyniku po\u0142\u0105czenia, podzia\u0142u, przekszta\u0142cenia, upad\u0142o\u015bci, restrukturyzacji lub nabycia Wykonawcy lub jego przedsi\u0119biorstwa, o ile nowy wykonawca spe\u0142nia warunki udzia\u0142u w post\u0119powaniu, nie zachodz\u0105 wobec niego podstawy wykluczenia oraz nie poci\u0105ga to za sob\u0105 innych istotnych zmian Umowy,\n- w wyniku przej\u0119cia przez Zamawiaj\u0105cego zobowi\u0105za\u0144 Wykonawcy wzgl\u0119dem jego podwykonawc\u00f3w.\n- zmiana Umowy nie prowadzi do zmiany jej charakteru, a \u0142\u0105czna warto\u015b\u0107 zmian jest mniejsza ni\u017c 215 000euro i jednocze\u015bnie jest mniejsza od 10% warto\u015bci pierwotnego Przedmiotu Umowy netto.\n\n- To reflect changes in the European Union or national law that affect the delivery of the services covered by the Contract (in particular changes in VAT rates);\n- To improve technical parameters of the services covered by the contract in line with new solutions brought about by technological advancements, without any effects on the gross flat rate;\n- To extend the deadline for the delivery of the services covered by the Contract due to additional works which need to be carried out to ensure proper delivery of the services covered by the Contract and which the Ordering Party, while exercising due diligence, could not have foreseen beforehand, subject below;\n- To extend the deadline for the delivery of the services covered by the Contract due to force majeure event(s), with any consequences of such an extension;\n- To change the parameters of the services covered by the Contract without altering the nature of the Contract \u2013 technology-related changes, in particular: the need to deliver the services covered by the Contract using other solutions \u2013 in terms of technology or materials \u2013 than those specified in the Request for Quotation in the event that the use of the original solutions could lead to non-delivery or improper delivery of the services covered by the Contract, subject to below;\n- To make changes with respect to additional deliveries or services to be provided by Contractor, which are not covered by the Contract, as long as they are necessary and when all of the following conditions are met:\n\u2013 Contractor cannot be replaced due to economic or technical reasons, in particular relating to the interchangeability or interoperability of equipment, services or systems contracted under the original Contract,\n\u2013 Contractor replacement could cause significant inconvenience or a material increase in costs for the Ordering Party,\n\u2013 each subsequent change does not exceed 50% of the original Contract net amount;\n- To make changes without altering the nature of the Contract, when all of the following conditions are met:\n\u2013 the Contract needs to be changed due to circumstances which could not have been foreseen by the Ordering Party while exercising due diligence,\n\u2013 the change does not exceed 50% of the original Contract net amount;\n- To replace Contractor with a new contractor:\n\u2013 as a result of merger, division, transformation, bankruptcy, restructuring or purchase of Contractor or its enterprise as long as the new contractor meets the conditions for participation in the procedure, there are no grounds for its exclusion and the change does not result in other material amendments to the Contract,\n\u2013 as a result of the Ordering Party taking over Contractor\u2019s obligations towards its subcontractors;\n- To amend the Contract without altering the nature of the Contract, when the total value of the amendments is less than EUR 215,000 and at the same time it is less than 10% of the original Contract net amount.","created_at":"2023-06-13 13:29:33","modified_at":"2023-06-13 13:32:02","contact_persons":[{"id":53911,"forename":"Barbara","surname":"Wendo\u0142owska","phone_number":"","email":"barbara.wendolowska@polpharma.com","created_by":null,"created_at":"2025-03-07 12:52:10","modified_at":"2025-03-07 12:52:10","modified_by":null}],"orders":[{"id":350372,"estimated_value":null,"order_items":[{"id":396508,"description":"W dniu 13.06.2023 skorygowano za\u0142\u0105cznik nr 1. Aktualny dokument za\u0142\u0105czono do og\u0142oszenia.\n\n\nPrzedmiotem zam\u00f3wienia jest przeprowadzenie nieklinicznego badania farmakodynamicznego dla kombinacji dw\u00f3ch substancji czynnych. Celem badania jest por\u00f3wnanie efektu obni\u017cenia ci\u015bnienia w ga\u0142ce oczne pomi\u0119dzy kombinacj\u0105 dw\u00f3ch substancji czynnych, a substancjami czynnymi podawanymi pojedynczo.\n\nW przypadku rozbie\u017cno\u015bci pomi\u0119dzy tre\u015bci\u0105 og\u0142oszenia a tre\u015bci\u0105 zapytania ofertowego stanowi\u0105cego za\u0142\u0105cznik do og\u0142oszenia o zam\u00f3wieniu, tre\u015b\u0107 zapytania jest wi\u0105\u017c\u0105ca.\nSzczeg\u00f3\u0142owe informacje dotycz\u0105ce zam\u00f3wienia znajduj\u0105 si\u0119 w za\u0142\u0105czniku Zapytanie ofertowe nr 2023-3084-161619\n\n\nThe subject of the contract is to conduct a non-clinical pharmacodynamic study for a combination of two active substances. The aim of the test is to compare the effect of lowering eye pressure between the combination of two active substances and the active substances administered individually.\n\nIn case of discrepancies between the content of the announcement and the content of the request for proposals attached to the contract announcement, the content of the request for proposals is binding.\nDetailed information regarding order are in appendix Request for Quotation No. 2023-3084-161619","warranty_period":"Nie dotyczy.","cpv_items":[{"id":8517,"code":"73120000-9","name":"Us\u0142ugi eksperymentalno-rozwojowe"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"mazowieckie","poviat":"Warszawa","commune":"Ochota","locality":"Warszawa","created_by":null,"created_at":"2023-06-13 13:29:33","modified_at":"2023-06-13 13:31:52","modified_by":null,"id":446398,"type":{"id":1,"name":"adres"},"group_uuid":"7246be50-30ac-4395-9f94-cf6c5fe2ba7b"}],"participation_conditions":[{"id":1083005,"description":"Zamawiaj\u0105cy uzna, \u017ce Wykonawca spe\u0142nia niniejszy warunek, je\u017celi Wykonawca wyka\u017ce, \u017ce posiada odpowiedni potencja\u0142 do wykonania zam\u00f3wienia:\n\nWykonawca ma mo\u017cliwo\u015b\u0107 przeprowadzenia cz\u0119\u015bci eksperymentalnej, a tak\u017ce analizy statystycznej wynik\u00f3w badania zgodnie z Dyrektyw\u0105 2010/63/EU oraz 2001/83/EC, a tak\u017ce obowi\u0105zuj\u0105cymi europejskimi wytycznymi, w tym:  \n\u2022\t\u2022\tICH Guidelines M3 (R2) on non-clinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals (EMA/CPMP/ICH/286/1995),\n\u2022\tGuideline on the Non-clinical development of fixed combinations of medicinal products (EMEA/CHMP/SWP/258498/2005),\n\u2022\tEMA/CHMP/SWP/2145/2000 Rev. 1, Corr. 1* Guideline on non-clinical local tolerance testing of medicinal products\n\nSpos\u00f3b oceny warunku:\nWeryfikacja warunku nast\u0105pi w oparciu o o\u015bwiadczenie o spe\u0142nieniu warunk\u00f3w udzia\u0142u w post\u0119powaniu (Za\u0142\u0105cznik nr 2 do Zapytania Ofertowego). Zamawiaj\u0105cy zastrzega sobie mo\u017cliwo\u015b\u0107 zweryfikowania zgodno\u015bci tre\u015bci o\u015bwiadczenia Wykonawcy ze stanem faktycznym oraz mo\u017cliwo\u015b\u0107 przeprowadzenia audytu u Wykonawcy.\n\n\nThe Contracting Authority shall consider that the Contractor meets this condition if the Contractor demonstrates that it has the appropriate capacity to perform the contract:\n\nThe contractor has the possibility to carry out the experimental part, as well as statistical analysis of the test results in accordance with Directives 2010/63/EU and 2001/83/EC, as well as applicable European guidelines, including:  \n\u2022\t\u2022\tICH Guidelines M3 (R2) on non-clinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals (EMA/CPMP/ICH/286/1995),\n\u2022\tGuideline on the Non-clinical development of fixed combinations of medicinal products (EMEA/CHMP/SWP/258498/2005),\n\u2022\tEMA/CHMP/SWP/2145/2000 Rev. 1, Corr. 1* Guideline on non-clinical local tolerance testing of medicinal products\n\nHow to assess the condition:\nThe condition will be verified on the basis of a statement on meeting the conditions for participation in the proceedings (Attachment No. 2 to the Request for Proposal). The Contracting Authority reserves the right to verify the compliance of the content of the Contractor's statement with the facts and the possibility of conducting an audit at the Contractor's.","type":{"id":3,"name":"Potencja\u0142 techniczny"},"created_by":null,"created_at":"2023-06-13 13:29:33","modified_at":"2023-06-13 13:29:33","modified_by":null,"group_uuid":"a950cdd0-6d12-4902-94c4-66493e1f5640"},{"id":1083006,"description":"Zamawiaj\u0105cy uzna, \u017ce Wykonawca spe\u0142nia niniejszy warunek, je\u017celi Wykonawca wyka\u017ce, \u017ce dysponuje odpowiednim personelem, w tym wykwalifikowan\u0105 kadr\u0105 naukow\u0105 (z wykszta\u0142ceniem \u015brednim lub wy\u017cszym weterynaryjnym, medycznym lub przyrodniczym), a tak\u017ce kluczowym personelem niezb\u0119dnym do wykonania zam\u00f3wienia, w tym przynajmniej jedn\u0105 osob\u0105 na stanowisku: G\u0142\u00f3wnego Badacza, Statystyka lub na r\u00f3wnorz\u0119dnym stanowisku. \nKa\u017cda z wy\u017cej wymienionych os\u00f3b stosownie do pe\u0142nionej funkcji musi: \na)\tposiada\u0107 do\u015bwiadczenie w prowadzeniu bada\u0144 nieklinicznych (dla G\u0142\u00f3wnego badacza min. 5-letnie do\u015bwiadczenie, dla Statystyka min. 5-letnie do\u015bwiadczenie, dla Kierownika Laboratorium Bioanalitycznego: min. 10-letnie do\u015bwiadczenie). \nb)\tposiada\u0107 wykszta\u0142cenie kierunkowe (dla G\u0142\u00f3wnego Badacza: weterynaria, medycyna, farmacja, biologia, chemia lub pokrewne; Statystyka: medycyna, biotechnologia, farmacja, biologia, chemia, matematyka, fizyka lub pokrewne), \nc)\tposiada\u0107 umiej\u0119tno\u015b\u0107 analizy wynik\u00f3w uzyskanych w badaniu nieklinicznym oraz prawid\u0142owego raportowania danych z bada\u0144 zgodne z odpowiednimi procedurami i standardami. \n\nKryteria kwalifikacji kluczowego personelu powinny by\u0107 zawarte w odpowiednich procedurach Wykonawcy.     \n\nSpos\u00f3b oceny warunku:\nWykonawca musi spe\u0142ni\u0107 wszystkie warunki \u0142\u0105cznie. Weryfikacja punkt\u00f3w a-c nast\u0105pi w oparciu o o\u015bwiadczenie o spe\u0142nieniu warunk\u00f3w udzia\u0142u w post\u0119powaniu (Za\u0142\u0105cznik nr 2 do Zapytania Ofertowego).\n\n\n\nThe Contracting Authority shall consider that the Contractor fulfils this condition if the Contractor demonstrates that it has appropriate personnel, including qualified scientific staff  (with secondary or higher veterinary, medical or natural sciences education), as well as key personnel necessary to perform the contract, including at least one person in the position of: Principal Investigator, Statistician or equivalent position.  \nEach of the above persons, in accordance with their function, must: \na) have experience in conducting \tnon-clinical trials (for the Principal Investigator min. 5 years of experience, for the Statistician min. 5 years of experience, for the Head of the Bioanalytical Laboratory: min. 10 years of experience). \nb) have a major education (for the Principal Investigator: \tveterinary medicine, medicine, pharmacy, biology, chemistry or related;   Statistics: medicine, biotechnology, pharmacy, biology, chemistry, mathematics, physics or related), \n(c)have the ability to analyse results obtained in a \tnon-clinical trial and to correctly report study data in accordance with relevant procedures and standards. \n\nThe qualification criteria for key personnel should be included in the relevant procedures of the Contractor.     \n\nHow to assess the condition:\nThe contractor must meet all conditions cumulatively. Verification of points a-c will be based on a statement on meeting the conditions for participation in the proceedings (Attachment No. 2 to the Request for Proposal).","type":{"id":4,"name":"Osoby zdolne do wykonania zam\u00f3wienia"},"created_by":null,"created_at":"2023-06-13 13:29:33","modified_at":"2023-06-13 13:29:33","modified_by":null,"group_uuid":"1365cdfe-7bfb-425b-b03c-317548325834"},{"id":1083007,"description":"Zamawiaj\u0105cy uzna, \u017ce Wykonawca spe\u0142nia niniejszy warunek, je\u017celi Wykonawca wyka\u017ce, \u017ce posiada odpowiedni potencja\u0142 do wykonania zam\u00f3wienia:\n\n1.\tWykonawca posiada do\u015bwiadczenie w prowadzeniu bada\u0144 nieklinicznych, w tym dla kombinacji substancji leczniczych.  \nZamawiaj\u0105cy uzna warunek za spe\u0142niony na podstawie o\u015bwiadczenia Wykonawcy (Za\u0142\u0105cznik 2), \u017ce wykona\u0142 co najmniej 10 bada\u0144 nieklinicznych, w tym co najmniej 2 badania dla kombinacji substancji leczniczych w okresie ostatnich 10 lat (je\u017celi okres funkcjonowania Wykonawcy jest kr\u00f3tszy, w okresie jego funkcjonowania)   \n\n2.\tWykonawca g\u0142\u00f3wnej cz\u0119\u015bci eksperymentalnej i statystycznej przedstawi list\u0119 inspekcji za okres 10 ostatnich lat  (je\u017celi okres funkcjonowania Wykonawcy jest kr\u00f3tszy - w okresie jego funkcjonowania) z podsumowaniem rezultatu inspekcji. Przynajmniej 1 inspekcja musi by\u0107 przeprowadzona przez stosowny urz\u0105d jednego z kraj\u00f3w Unii Europejskiej w zakresie GLP (Dobrej Praktyki Laboratoryjnej), a rezultaty wszystkich inspekcji w podanym okresie nie mog\u0105 zawiera\u0107 niezgodno\u015bci krytycznych. Inspekcje bada\u0144 przeprowadzonych przez Wykonawc\u0119 przed 2012 r. nie b\u0119d\u0105 brane pod uwag\u0119. \n\nZamawiaj\u0105cy uzna warunek za spe\u0142niony na podstawie o\u015bwiadczenia Wykonawcy (Za\u0142\u0105cznik 2) oraz przestawienia w/w listy inspekcji.\n\nSpos\u00f3b oceny warunku:\nWykonawca musi spe\u0142nia\u0107 wszystkie wymagane wymagania \u0142\u0105cznie. Zamawiaj\u0105cy uzna warunek za spe\u0142niony na podstawie o\u015bwiadczenia Wykonawcy (Za\u0142\u0105cznik nr 2 do Zapytania Ofertowego), listy zwalidowanych metod analitycznych o kt\u00f3rych mowa w pkt. 1 oraz listy inspekcji o kt\u00f3rej mowa w pkt. 3 .\n\n\nThe Contracting Authority shall consider that the Contractor meets this condition if the Contractor demonstrates that it has the appropriate capacity to perform the contract:\n\n1. The contractor has experience in conducting \tnon-clinical studies, including for combinations of medicinal substances.  \nThe Contracting Authority shall consider the condition to be fulfilled on the basis of the Contractor's declaration (Appendix 2) that it has performed at least 10 non-clinical tests, including at least 2 tests for a combination  of medicinal substances in the last 10 years (if the period of the Contractor's operation is shorter, during its operation) \n\n2. The  Contractor of the main  experimental  and  statistical part  shall present a list of inspections for the period of the last 10 years (if the period of the Contractor's operation is shorter - during its period of operation) with a summary of the inspection result. At least 1 inspection must be carried out by the appropriate GLP (Good Laboratory Practice) authority of one of the European Union countries, and the results of all inspections in the given period must not contain critical non-compliances. Inspections of tests carried out by the Contractor before 2012 will not be taken into account. \n\nThe Contracting Authority shall consider the condition to be fulfilled on the basis of the Contractor's statement (Appendix 2) and presentation of the above-mentioned inspection list.\n\nHow to assess the condition:\nThe contractor must meet all the required requirements jointly. The Contracting Authority shall consider the condition to be fulfilled on the basis of the Contractor's statement (Appendix No. 2 to the Request for Quotation), the list of validated analytical methods referred to in point 1 and the inspection list referred to in point 3.","type":{"id":2,"name":"Wiedza i do\u015bwiadczenie"},"created_by":null,"created_at":"2023-06-13 13:29:33","modified_at":"2023-06-13 13:29:33","modified_by":null,"group_uuid":"711c3a81-c878-4108-94df-94f82cd1bc7e"},{"id":1083008,"description":"Z udzia\u0142u w post\u0119powaniu wykluczone s\u0105 podmioty powi\u0105zane osobowo lub kapita\u0142owo z Zamawiaj\u0105cym.\nPrzez powi\u0105zania kapita\u0142owe lub osobowe rozumie si\u0119 wzajemne powi\u0105zania mi\u0119dzy Zamawiaj\u0105cym lub osobami upowa\u017cnionymi do zaci\u0105gania zobowi\u0105za\u0144 w imieniu Zamawiaj\u0105cego lub osobami wykonuj\u0105cymi w imieniu Zamawiaj\u0105cego czynno\u015bci zwi\u0105zane z przygotowaniem i przeprowadzaniem procedury wyboru wykonawcy, a Wykonawc\u0105, polegaj\u0105ce w szczeg\u00f3lno\u015bci na:\na)\tuczestniczeniu w sp\u00f3\u0142ce jako wsp\u00f3lnik sp\u00f3\u0142ki cywilnej lub sp\u00f3\u0142ki osobowej,\nb)\tposiadaniu co najmniej 10% udzia\u0142\u00f3w lub akcji,\nc)\tpe\u0142nieniu funkcji cz\u0142onka organu nadzorczego lub zarz\u0105dzaj\u0105cego, prokurenta, pe\u0142nomocnika,\nd)\tpozostawaniu w zwi\u0105zku ma\u0142\u017ce\u0144skim, w stosunku pokrewie\u0144stwa lub powinowactwa w linii prostej, pokrewie\u0144stwa drugiego stopnia lub powinowactwa drugiego stopnia w linii bocznej lub w stosunku przysposobienia, opieki lub kurateli \nSpos\u00f3b oceny spe\u0142niania braku podstaw wykluczenia:\nWeryfikacja nast\u0105pi w oparciu o o\u015bwiadczenie Wykonawcy o braku ww. powi\u0105za\u0144 osobowych lub kapita\u0142owych z Zamawiaj\u0105cym wg za\u0142\u0105cznika nr 2 do Zapytania Ofertowego.\nZ udzia\u0142u w post\u0119powaniu wykluczone s\u0105 podmioty wskazane w ustawie z dnia 13 kwietnia 2022 r. o szczeg\u00f3lnych rozwi\u0105zaniach w zakresie przeciwdzia\u0142ania wspieraniu agresji na Ukrain\u0119 oraz s\u0142u\u017c\u0105cych ochronie bezpiecze\u0144stwa narodowego. \nSpos\u00f3b oceny spe\u0142niania braku podstaw wykluczenia:\nWeryfikacja nast\u0105pi w oparciu o o\u015bwiadczenie Wykonawcy o braku ww. powi\u0105za\u0144 osobowych lub kapita\u0142owych z Zamawiaj\u0105cym wg za\u0142\u0105cznika nr 2 do Zapytania Ofertowego.\n\nEntities with personal or capital ties with the Ordering Party are excluded from the procedure.\nThe capital or personal ties mean mutual ties between Contractor and the Ordering Party or persons authorized to contract obligations on behalf of the Ordering Party, or persons performing, on behalf of the Ordering Party, any actions involved in the preparation and conduct of the contract award procedure, including in particular:\na)\tparticipation in a partnership (sp\u00f3\u0142ka cywilna or sp\u00f3\u0142ka osobowa under Polish law),\nb)\tholding at least 10% of stocks or shares,\nc)\tserving as a member of a supervisory or management body, a commercial representative or an attorney,\nd)\tbeing married or having direct lineal consanguinity or affinity, second degree of collateral consanguinity or affinity, or being adopted by, under guardianship or custody.\nAssessment of bids in terms of the grounds for exclusion:\nBids will be assessed in terms of the grounds for exclusion based on Contractor\u2019s declaration of absence of personal or capital ties with the Ordering Party as per Appendix 2 to the Request for Quotation.\nEntities indicated in the Act of April 13, 2022 on special solutions in the field of preventing the support of aggression against Ukraine and to protect of national security are excluded from the procedure.\nAssessment of bids in terms of the grounds for exclusion:\nBids will be assessed in terms of the grounds for exclusion based on Contractor\u2019s declaration of absence of personal or capital ties with the Ordering Party as per Appendix 2 to the Request for Quotation.","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2023-06-13 13:29:33","modified_at":"2023-06-13 13:29:33","modified_by":null,"group_uuid":"d781ff59-de45-4cd1-baf0-10dd4356495e"},{"id":1083009,"description":"Wykonawca znajduje si\u0119 w sytuacji ekonomicznej i finansowej zapewniaj\u0105cej terminowe i zgodne z wymaganiami wykonanie przedmiotowego zam\u00f3wienia, nie znajduje si\u0119 w stanie upad\u0142o\u015bci oraz nie toczy si\u0119 w stosunku do niego post\u0119powanie likwidacyjne b\u0105d\u017a naprawcze. \nSpos\u00f3b oceny warunku:\nZamawiaj\u0105cy uzna, \u017ce Wykonawca spe\u0142nia niniejszy warunek, je\u017celi Wykonawca z\u0142o\u017cy o\u015bwiadczenie o spe\u0142nieniu warunk\u00f3w udzia\u0142u w post\u0119powaniu (Za\u0142\u0105cznik nr 2 do Zapytania Ofertowego).\n\n\nThe contractor is in an economic and financial situation ensuring timely and compliant performance of the contract in question, is not in bankruptcy and is not subject to liquidation or reorganization proceedings. \nHow to assess the condition:\nThe Contracting Authority shall consider that the Contractor meets this condition if the Contractor submits a statement on meeting the conditions for participation in the procedure (Appendix 2 to the Request for Proposal).","type":{"id":5,"name":"Sytuacja ekonomiczna i finansowa"},"created_by":null,"created_at":"2023-06-13 13:29:33","modified_at":"2023-06-13 13:29:33","modified_by":null,"group_uuid":"e2dbbdb5-dbdb-4023-8c21-dd47c518fb84"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":8,"name":"Us\u0142ugi inne"},"created_by":null,"created_at":"2023-06-13 13:29:33","modified_at":"2023-06-13 13:31:52","modified_by":null,"group_uuid":"305b74a8-3468-4907-b348-c982797dc4c0"}],"evaluation_criteria":[{"id":606092,"price_criterion":true,"description":"Cena obliczana b\u0119dzie dla ceny netto wg:\nPC=Cena najta\u0144szej oferty/Oferowana cena *50 pkt\n\nPC-liczba punkt\u00f3w za kryterium \u201eCena\u201d\n\nThe score for the Price, formula: \nPc=out of non-rejected bids, the lowest total net price of the bid/total net price of the bid x 50 pts\n\nPC - score for the Price","created_by":null,"created_at":"2023-06-13 13:29:33","modified_at":"2023-06-13 13:29:33","modified_by":null,"group_uuid":"260901d8-1061-4180-a5eb-8f151d332f3a"},{"id":606093,"price_criterion":false,"description":"Czas realizacji zam\u00f3wienia obliczany wed\u0142ug wzoru:\nPt= Najkr\u00f3tszy czas realizacji ofert niepodlegaj\u0105cych odrzuceniu/Oferowany czas realizacji*50 pkt\n\n\nThe score for the delivery time formula: \nPt=out of non-rejected bids, the lowest delivery time of the bid/delivry time of the bid x 50 pts","created_by":null,"created_at":"2023-06-13 13:29:33","modified_at":"2023-06-13 13:29:33","modified_by":null,"group_uuid":"33ac6045-6b7c-4825-a720-95576897e75b"}],"is_variant":false,"title":"Us\u0142uga eksperymentalno-rozwojowa","order_node":{"id":265576},"created_by":null,"created_at":"2023-06-13 13:29:33","modified_at":"2023-06-13 13:31:52","modified_by":null}],"created_by":{"id":3084,"contact_persons":[]},"modified_by":{"id":3084,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"Warszawskie Zak\u0142ady Farmaceutyczne Polfa S.A.","identification_number_type":"nip","identification_number":"5250000481","address":{"country":"Polska","voivodeship":"mazowieckie","poviat":"Warszawa","commune":"Ochota","locality":"Warszawa","created_by":{"id":3084,"contact_persons":[]},"created_at":"2023-06-13 13:29:33","modified_at":"2023-06-13 13:29:33","modified_by":{"id":3084,"contact_persons":[]},"id":555575,"street":"Karolkowa","number_description":"22/24","postcode":"01-207"},"created_by":{"id":3084,"contact_persons":[]},"created_at":"2023-06-13 13:29:33","modified_at":"2023-06-13 13:29:33","modified_by":{"id":3084,"contact_persons":[]},"id":213150},"advertisement":{"id":161619,"number":"2023-3084-161619","publication_date":"2023-06-07","created_by":{"id":3084,"contact_persons":[]},"created_at":"2023-06-07 12:28:01","modified_at":"2023-06-15 14:06:16","modified_by":{"id":3084,"contact_persons":[]},"status":{"id":4,"label":"CANCELLED","name":"Anulowane"},"all_available_version_ids":[211881,212666],"enrollment":{"id":38488,"name":"Opracowanie innowacyjnego produktu leczniczego w postaci kropli do oczu, stosowanych do obni\u017cenia ci\u015bnienia \u015br\u00f3dga\u0142kowego, wolnych od konserwant\u00f3w, dostarczanych w opakowaniu wielodawkowym","number":"002/23","activity":{"created_by":null,"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":null},"region":null,"institution":{"created_by":null,"created_at":"2023-02-01 09:27:55","modified_at":"2023-02-01 09:27:55","modified_by":null},"full_number":"FENG.01.01-IP.01-002/23","perspective":{},"programme":{"created_by":null,"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":null},"priority":{"created_by":null,"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":null},"type":"enrollment","created_by":null,"created_at":"2023-06-01 16:45:53","modified_at":"2023-06-01 16:45:53","modified_by":null},"projects":[],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":211881,"publication_date":"2023-06-07"},"id":1031757,"name":"zapytanie ofertowe 2023-3084-161619","file":{"id":1149698,"name":"Zapytanie_ofertowe_nr 2023-3084-161619.pdf","created_at":"2023-06-13 13:29:33","created_by":{"forename":"Pawe\u0142","surname":"Brzezi\u0144ski"},"uri":"/api/files/1149698"},"group_uuid":"05a8a4b9-dea3-49d9-b726-67937814be83"},{"origin":{"id":211881,"publication_date":"2023-06-07"},"id":1031758,"name":"price inquiry 2023-3084-161619","file":{"id":1149700,"name":"PRICE INQUIRY No 2023-3084-161619.pdf","created_at":"2023-06-13 13:29:33","created_by":{"forename":"Pawe\u0142","surname":"Brzezi\u0144ski"},"uri":"/api/files/1149700"},"group_uuid":"59307ac9-23cc-4492-8341-8bc364e11c91"},{"origin":{"id":211881,"publication_date":"2023-06-07"},"id":1031759,"name":"za\u0142\u0105cznik nr 1","file":{"id":1149703,"name":"Za\u0142\u0105cznik nr 1 do Zapytania Ofertowego.docx","created_at":"2023-06-13 13:29:33","created_by":{"forename":"Pawe\u0142","surname":"Brzezi\u0144ski"},"uri":"/api/files/1149703"},"group_uuid":"ff757f0f-c892-40d4-9269-30dd276a3454"},{"origin":{"id":211881,"publication_date":"2023-06-07"},"id":1031760,"name":"attachment no 1","file":{"id":1149706,"name":"Attachement No 1.docx","created_at":"2023-06-13 13:29:33","created_by":{"forename":"Pawe\u0142","surname":"Brzezi\u0144ski"},"uri":"/api/files/1149706"},"group_uuid":"97a0f871-0c85-4757-8295-6cd2e6e10d4c"},{"origin":{"id":211881,"publication_date":"2023-06-07"},"id":1031761,"name":"za\u0142\u0105cznik nr 2","file":{"id":1149708,"name":"Za\u0142\u0105cznik nr 2 do Zapytania Ofertowego.docx","created_at":"2023-06-13 13:29:33","created_by":{"forename":"Pawe\u0142","surname":"Brzezi\u0144ski"},"uri":"/api/files/1149708"},"group_uuid":"56455d53-f38f-4230-aec2-ed40fbae80c8"},{"origin":{"id":211881,"publication_date":"2023-06-07"},"id":1031762,"name":"attachment no 2","file":{"id":1149709,"name":"Attachement  No 2.docx","created_at":"2023-06-13 13:29:33","created_by":{"forename":"Pawe\u0142","surname":"Brzezi\u0144ski"},"uri":"/api/files/1149709"},"group_uuid":"da0552dc-74ac-4739-90e5-5be6550dc59e"},{"origin":{"id":211881,"publication_date":"2023-06-07"},"id":1031763,"name":"za\u0142\u0105cznik nr 3","file":{"id":1149710,"name":"Za\u0142\u0105cznik nr 3 do Zapytania Ofertowego.docx","created_at":"2023-06-13 13:29:33","created_by":{"forename":"Pawe\u0142","surname":"Brzezi\u0144ski"},"uri":"/api/files/1149710"},"group_uuid":"2aa0307b-646c-48f0-b36e-b7e093a8ecb3"},{"origin":{"id":211881,"publication_date":"2023-06-07"},"id":1031764,"name":"attachment no 3","file":{"id":1149711,"name":"Attachement No 3.docx","created_at":"2023-06-13 13:29:33","created_by":{"forename":"Pawe\u0142","surname":"Brzezi\u0144ski"},"uri":"/api/files/1149711"},"group_uuid":"01fc0a90-b5d7-4880-8c91-56d34ab34bf0"},{"origin":{"id":211881,"publication_date":"2023-06-07"},"id":1031765,"name":"za\u0142\u0105cznik nr 4","file":{"id":1149712,"name":"Za\u0142\u0105cznik nr 4 do Zapytania Ofertowego.docx","created_at":"2023-06-13 13:29:33","created_by":{"forename":"Pawe\u0142","surname":"Brzezi\u0144ski"},"uri":"/api/files/1149712"},"group_uuid":"a36d52ff-76fe-45ee-afdb-9eb867ffac14"},{"origin":{"id":211881,"publication_date":"2023-06-07"},"id":1031766,"name":"attachment no 4","file":{"id":1149713,"name":"Attachment No 4.docx","created_at":"2023-06-13 13:29:33","created_by":{"forename":"Pawe\u0142","surname":"Brzezi\u0144ski"},"uri":"/api/files/1149713"},"group_uuid":"db87ad89-30d2-4272-9d0f-22883b0e23c7"},{"origin":{"id":212666,"publication_date":"2023-06-13"},"id":1035383,"name":"ZA\u0141\u0104CZNIK NR 1 SKORYGOWANY","file":{"id":1153765,"name":"Za\u0142\u0105cznik nr 1 do Zapytania Ofertowego-skorygowany.docx","created_at":"2023-06-13 13:28:48","created_by":{"forename":"Pawe\u0142","surname":"Brzezi\u0144ski"},"uri":"/api/files/1153765"},"group_uuid":"f58c8a66-d171-4e31-821a-916f455ebd40"},{"origin":{"id":212666,"publication_date":"2023-06-13"},"id":1035384,"name":"ATTACHMENT NO 1 CORRECTED","file":{"id":1153766,"name":"Attachement No 1-corrected.docx","created_at":"2023-06-13 13:29:05","created_by":{"forename":"Pawe\u0142","surname":"Brzezi\u0144ski"},"uri":"/api/files/1153766"},"group_uuid":"b587b6a7-c7cb-4adc-bd08-3b98f8382feb"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}